Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Arius Research begins preparations for phase I clinical trials of cancer-killing antibodies

July 20, 2001

Mechanism of action of Mylotarg in AML elucidated

July 20, 2001

Licensing opportunity from NIH: beta2-microglobulin fusion proteins

July 17, 2001

Positive long-term survival and safety data reported for OvaRex

July 16, 2001

MabCampath approved in Europe for B-CLL

July 13, 2001

TheraCIM h-R3 enters phase I/II for additional indication

July 12, 2001

Pharmexa begins phase I/II trial of therapeutic vaccine for breast cancer in Denmark

July 11, 2001

Ivax boosts immunotoxin program with new agreement

July 11, 2001

PSK evaluated in clinical trials as adjuvant immunochemotherapy in colorectal cancer

July 5, 2001

Combination therapies for certain malignancies discussed by Idec

June 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...